GI ASC market not deterred by COVID-19, could hit $10.27B by 2027

The U.S. gastroenterology ASC market was worth $7.21 billion in 2019 and is expected to grow at a compound annual growth rate of 5.8 percent through 2027 to hit $10.27 billion, according to a Reports Globe report.

Leading companies in the market include:

  • Olympus
  • Johnson & Johnson
  • Medtronic
  • GE Healthcare
  • Boston Scientific
  • Cardinal Health

The majority of centers are either affiliated with a hospital, freestanding or physician-owned.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast